Daniel Hackam MD, PhD, FRCPC

Daniel Gidon Hackam BSc MD PhD FRCPC is an Associate Professor in the Divisions of Clinical Pharmacology and Clinical Neurological Sciences and the Department of Epidemiology and Biostatistics. Dr. Hackam is a scientist at the Robarts Research Institute, Clinical Trials Research Group, and Vascular Biology Group. His research is diverse and focuses on the pharmacoepidemiology of atherosclerosis, risk factor assessment, and translation of novel findings from basic science to clinical trials. His background includes training in internal medicine, clinical pharmacology, cardiac rehabilitation, clinical epidemiology, and health services research. Dr. Hackam’s publications have appeared in The Lancet, JAMA, Circulation, Stroke, Neurology, American Journal of Medicine, CMAJ, BMJ, and in numerous research forums and symposia.